CHP
RMD icon

Cable Hill Partners’s ResMed RMD Stock Holding History

Cable Hill Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$201K Buy
+850
New +$198K 0.02% 216
2024
Q4 		– Sell
-865
Closed -$211K – 252
2024
Q3 		$211K Buy
+865
New +$193K 0.02% 223

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Cable Hill Partners's RMD Position: Q1 2025 in Review

Cable Hill Partners opened a new position in ResMed (RMD) in Q1 2025: 850 shares worth $201K. The stake represents 0.02% of the portfolio and ranks #216 among its holdings. This is a return to the name: Cable Hill Partners previously reported a position in RMD as recently as Q3 2024.

Cable Hill Partners first reported a position in RMD in Q3 2024 and has held it in 2 quarters since. The position peaked at $211K in Q3 2024. 886 funds tracked by Wall St. Rank hold RMD as of Q1 2025.

  • Cable Hill Partners held 850 shares of ResMed worth $201K as of Q1 2025.
  • ResMed was a new Cable Hill Partners position in Q1 2025.
  • ResMed made up 0.02% of Cable Hill Partners's portfolio in Q1 2025, its #216 holding.
  • Cable Hill Partners first reported a position in ResMed in Q3 2024 and has held it in 2 quarters since.
  • Cable Hill Partners's ResMed position peaked at $211K in Q3 2024.
  • 886 funds tracked by Wall St. Rank held ResMed as of Q1 2025.

Based on Cable Hill Partners's 13F filing for Q1 2025, filed 2 May 2025.